Comprehensive Cancer Center Core Support Grant

$3,827,965P30FY2019CANIH

University Of Alabama At Birmingham, Birmingham AL

Investigators

Linked publications & trials

Paper 39713459 Paper 39642329 Paper 39604120 Paper 39553825 Paper 39489766 Paper 39464096 Paper 39386666 Paper 39377264 Paper 39361227 Paper 39323387 Paper 39255453 Paper 39240686 Paper 39218899 Paper 39199623 Paper 39149492 Paper 38956234 Paper 38948780 Paper 38935616 Paper 38918836 Paper 38867704 Paper 38849476 Paper 38824070 Paper 38772123 Paper 38766241 Paper 38743486 Paper 38570263 Paper 38539515 Paper 38530365 Paper 38518528 Paper 38467087 Paper 38451522 Paper 38277493 Paper 38262310 Paper 38250045 Paper 38241154 Paper 38154167 Paper 38150547 Paper 38150142 Paper 38135177 Paper 38114543 Paper 38106208 Paper 38086808 Paper 38068776 Paper 38039923 Paper 38011564 Paper 37946177 Paper 37931781 Paper 37919169 Paper 37895177 Paper 37892669 Paper 37850446 Paper 37782053 Paper 37776872 Paper 37717172 Paper 37660914 Paper 37643018 Paper 37640572 Paper 37626587 Paper 37578272 Paper 37552575 Paper 37495106 Paper 37483698 Paper 37479754 Paper 37428799 Paper 37398342 Paper 37398202 Paper 37384638 Paper 37382447 Paper 37380890 Paper 37365848 Paper 37345044 Paper 37327322 Paper 37287117 Paper 37246417 Paper 37240357 Paper 37226942 Paper 37192295 Paper 37177979 Paper 37142223 Paper 37067340 Paper 37058110 Paper 37046795 Paper 37046042 Paper 37034637 Paper 37014961 Paper 36968227 Paper 36958335 Paper 36926842 Paper 36922679 Paper 36907775 Paper 36904284 Paper 36900368 Paper 36882605 Paper 36865329 Paper 36775449 Paper 36735117 Paper 36724083 Paper 36711885 Paper 36711747 Paper 36697463

Abstract

PROJECT SUMMARY - OVERALL The UAB CCC is the only NCI designated comprehensive cancer center in the states of Alabama, Mississippi, Louisiana and Arkansas, states with higher cancer mortality and significant minority, mostly African American populations. The Cancer Center is in its 46th year of NCI funding and continues its major contributions to translational therapeutics and cancer disparity research. The UAB CCC has 222 members who come from 30 departments in 9 UAB schools, Southern Research, and HudsonAlpha Institute for Biotechnology. The members are supported by $63,509,616 in cancer-relevant annual direct extramural funding. The UAB CCC is organized into six research programs, two each in basic, translational, and prevention and control ? Inflammation, Immunology & Immunotherapeutics; Cancer Cell Biology; Experimental Therapeutics; Neuro-Oncology; Cancer Chemoprevention; and Cancer Control & Population Sciences. Members published 1,967 cancer focused, peer reviewed publications from 2016 through 2018 of which 24% were intra-programmatic, 24% inter-programmatic, and 70% inter-institutional. These members are supported by eleven shared facilities ? Biostatistics & Bioinformatics, Comprehensive Genomics, High Resolution Imaging, Human Imaging, Mass Spectrometry/2D Proteomics, Microbiome/Gnotobiotic, Preclinical Imaging, Recruitment & Retention, Structural Biology, Tissue Procurement, and Transgenic Animals as well as the developing Pharmacometrics Shared Facility. We have established a Phase I Clinical Trials Program, opened an Advanced Imaging Facility, advanced targets through the Alabama Drug Discovery Alliance, created the UAB Health System Cancer Community Network, and are now a consortium with HudsonAlpha Institute for Biotechnology. In addition to these achievements, we have created an Institute for Cancer Outcomes and Survivorship, and established a critical mass of investigators in energy balance and cancer. Strategic plans updated in 2018 with crosscutting themes of Translational Therapeutics, Systems Biology, and Energetics and Cancer continue to be highly relevant today. For the future, we will continue to emphasize translational and cancer disparity research with an emphasis on personalized/genomic medicine, energy balance and cancer, outcomes and survivorship, and early phase clinical trials.

View original record on NIH RePORTER →